CrushSCI.com
80平均天数
69.5中位天数
8最短天数
215最长天数
1682025发文量

Paper Review Records

全部论文审稿周期

30 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

26 天

Pediatric Pharmacodynamic Differences Challenge Exposure‐Matched Intranasal Epinephrine Dosing

作者
Ercan Yılmaz; Nezihe Koker Ozer; Erdem Topal展开收起
作者单位
1. Pediatric Allergy and Immunology Department Faculty of Medicine Inonu University Malatya Turkey展开收起
PDF源文件 DOI 网页
31 天

Pain Severity Trajectories and Patient Profiles in Chronic Pain Patients Treated with Cannabis‐Based Medicinal Products: A k‐Means Clustering Analysis of the UK Medical Cannabis Registry

作者
Simon Erridge; Aritra Datta; Aditya Mukherjee; Dhruv Vasooja; Ross Coomber; Sushil Beri; Shaheen A. Khan; Mark W. Weatherall; Michael W. Platt; James J. Rucker; Pedro A. M. Mediano; Mikael H. Sodergren展开收起
作者单位
1. Medical Cannabis Research Group Department of Surgery and Cancer Imperial College London London UK; 2. Curaleaf Clinic Curaleaf International London UK; 3. St. George's Hospital London UK; 4. Imperial College Healthcare NHS Trust London UK; 5. Guy's and St. Thomas' NHS Foundation Trust London UK; 6. Buckinghamshire Healthcare NHS Trust Amersham UK; 7. Department of Psychological Medicine King's College London London UK; 8. South London and Maudsley NHS Foundation Trust London UK; 9. Department of Computing Imperial College London London UK展开收起
PDF源文件 DOI 网页
64 天

Fostering Clinical Pharmacology and Drug Development in India: A Perspective From SAC‐ACCP

作者
Karthik Venkatakrishnan; Abhigyan Ravula; Sagar Bachhav; Mohammad Faruq; Bratati Kahali; AVS Suresh; Sanish Davis; Manish Lavhale; Amruta Gadade; Gurusharan Dumra; Vikas Dighe; Vipin Dhote; Bikash Medhi; Kiran Marthak; Nirmala Rege; Tushar Garimella; Taruna Madan; Jagannath Kota; Ravi Shankar P. Singh; Gangadhar Sunkara; Manoj Jadhav; Nilima Kshirsagar; Deven Parmar展开收起
作者单位
1. Clinical Pharmacology & Quantitative Pharmacology Clinical Pharmacology & Safety Sciences R&D, AstraZeneca Waltham MA USA; 2. Quantitative Pharmacology and Pharmacometrics Merck & Co., Inc. Rahway NJ USA; 3. CSIR‐Institute of Genomics and Integrative Biology Delhi India; 4. Centre for Brain Research Indian Institute of Science Bengaluru India; 5. AOI Hospital Hyderabad India; 6. Clinical Sciences Oncology Takeda Biopharmaceuticals India Pvt. Ltd. Mumbai India; 7. Pharmazz India Private Limited Greater Noida India; 8. National Centre for Preclinical Reproductive and Genetic Toxicology ICMR‐National Institute for Research in Reproductive and Child Health Jehangir Merwanji Street Mumbai India; 9. Department of Pharmacology Narendra Modi Medical College Ahmedabad India; 10. VNS Group of Institutions Faculty of Pharmacy Bhopal India; 11. Department of Pharmacology Postgraduate Institute of Medical Education and Research (PGIMER) Chandigarh India; 12. Veeda Lifesciences Ahmedabad India; 13. Department of Pharmacology Era's Lucknow University, Lucknow India; 14. Daiichi Sankyo Inc. Baskin Ridge NJ USA; 15. Development Research, Indian Council of Medical Research, V. Ramalingaswami Bhawan New Delhi India; 16. Novartis Healthcare Private Limited Salarpuria Sattva Knowledge City Hyderabad India; 17. Clinical Pharmacology Group Lead Pfizer Inc. Cambridge MA USA; 18. Novartis Pharmaceuticals East Hanover NJ USA; 19. ISHA Therapeutics Hillsborough NJ USA; 20. National Academy of Medical Sciences, New Delhi Maharashtra University of Health Sciences,Nashik,422004 India; 21. Clinical RnD Zydus Therapeutics Inc. 73C Route 31N Pennington NJ USA展开收起
PDF源文件 DOI 网页
169 天

Development and Evaluation of a Population Pharmacokinetic Model for High‐Dose Methotrexate in Japanese Pediatric Patients with Acute Lymphoblastic Leukemia

作者
Takuya Suzuoka; Tsubura Noda; Kota Tsuge; Yasuyoshi Ishiwata; Toshinori Hirai; Takeshi Isoda; Masatoshi Takagi; Masashi Nagata展开收起
作者单位
1. Department of Pharmacy Institute of Science Tokyo Hospital Tokyo Japan; 2. Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences Institute of Science Tokyo Tokyo Japan展开收起
PDF源文件 DOI 网页
65 天

Population Pharmacokinetics and Exposure–Response of Sasanlimab, a Checkpoint Inhibitor, in Patients with Non‐Muscle Invasive Bladder Cancer and Other Solid Tumors

作者
Joanna C. Masters; Brian Jermain; Alan Liu; Rossano Cesari; Anna Maria Calella; Elisabete Michelon; Caimiao Wei; Susana Liu; Joseph Piscitelli展开收起
作者单位
1. Pfizer Inc. San Diego CA USA; 2. Pfizer Inc. New York NY USA; 3. Pfizer SRL Milan Italy; 4. Pfizer SRL Rome Italy; 5. Pfizer Inc. Quebec Canada展开收起
PDF源文件 DOI 网页
97 天

The Rise of the Digital Health Technology–AI Coupled System in the AI Era of Drug Development

作者
Hanrui Zhang; Gabriel K. Innes; Jonas Santiago; Ayoub Suliman; Norah Xiao; Hao Zhu; Dianne Paraoan; Jeffery Siegel; Yutao Gong; Ruihao Huang; Menglun Wang; Lixia Zhang; Qi Liu展开收起
作者单位
1. Office of Clinical Pharmacology Office of Translational Sciences, Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring MD USA; 2. Office of Medical Policy, Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring MD USA; 3. Office of Drug Evaluation Sciences Office of New Drugs, Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring MD USA展开收起
PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。